Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rhox homeobox family member 1 pseudogene 3 (RHOXF1P3) is a human pseudogene belonging to the Rhox homeobox gene family, typically located on the X chromosome. Unlike classic protein-coding genes, RHOXF1P3 is officially classified as a pseudogene; however, recent studies demonstrate its RNA is highly expressed in certain cancers (especially breast and ovarian), and mass spectrometry data support the existence of peptides derived from its open reading frame in tumors, marking it as a potential source of novel cancer-associated peptide antigens (“dark antigens”) [1][3]. While pseudogenes usually lack protein-coding function, evidence for translation in this case suggests a possibly unique biological or immunological relevance, although its precise cellular role and mechanism remain unclear [1][3]. RHOXF1P3 is not a receptor, enzyme, or classic drug target, nor are there drugs known to act through it, but its upregulation in cancer and potential translation to tumor antigens may make it a subject of future investigation for cancer immunotherapy or as a biomarker [1][3][5]. No common aliases are reported, and no safety concerns or established function in normal physiology are known. The broader Rhox gene family encodes homeobox transcription factors involved in reproductive tissue development and germline maintenance, though RHOXF1P3 itself is considered functionally distinct due to its status as a pseudogene and possible neoantigen source [1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rhox homeobox family member 1 pseudogene 3 (RHOXF1P3).